Evidence map›Paper›PMID 22771948›Full record

ArticleTranscription

The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes.

Yi Qing He, Elissa L Sutcliffe, Karen L Bunting, Jasmine Li, Katharine J Goodall, Ivan K A Poon, Mark D Hulett, Craig Freeman, Anjum Zafar, Russell L McInnes and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Transcription. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Heparanase Regulatory Network in Health and Disease.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Review
  12. New classes of potent heparanase inhibitors from ligand-based virtual screening.Journal of enzyme inhibition and medicinal chemistry · 2020
    Article
  13. Heparanase and the hallmarks of cancer.Journal of translational medicine · 2020
    Review
  14. Significance of host heparanase in promoting tumor growth and metastasis.Matrix biology : journal of the International Society for Matrix Biology · 2020
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Heparanase: A Dynamic Promoter of Myeloma Progression.Advances in experimental medicine and biology · 2020
    Review
  20. Forty Years of Basic and Translational Heparanase Research.Advances in experimental medicine and biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

Yi Qing HeDepartment of Immunology, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
Elissa L Sutcliffe
Karen L Bunting
Jasmine Li
Katharine J Goodall
Ivan K A Poon
Mark D Hulett
Craig Freeman
Anjum Zafar
Russell L McInnes
Toshiki Taya
Christopher R Parish
Sudha Rao
Curtin University · AULa Trobe University · AUAgilent Technologies (Germany) · DEFaculty (United Kingdom) · GBAustralian National University · AUNew York Proton Center · USUniversity of Canberra · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The methylation of histones is a fundamental epigenetic process regulating gene expression programs in mammalian cells. Dysregulated patterns of histone methylation are directly implicated in malignant transformation. Here, we report the unexpected finding that the invasive extracellular matrix degrading endoglycosidase heparanase enters the nucleus of activated human T lymphocytes and regulates the transcription of a cohort of inducible immune response genes by controlling histone H3 methylation patterns. It was found that nuclear heparanase preferentially associates with euchromatin. Genome-wide ChIP-on-chip analyses showed that heparanase is recruited to both the promoter and transcribed regions of a distinct cohort of transcriptionally active genes. Knockdown and overexpression of the heparanase gene also showed that chromatin-bound heparanase is a prerequisite for the transcription of a subset of inducible immune response genes in activated T cells. Furthermore, the actions of heparanase seem to influence gene transcription by associating with the demethylase LSD1, preventing recruitment of the methylase MLL and thereby modifying histone H3 methylation patterns. These data indicate that heparanase belongs to an emerging class of proteins that play an important role in regulating transcription in addition to their well-recognized extra-nuclear functions.

Indexed as

Transcriptional ActivationAnimalsCell Line, TumorCell NucleusChromatinEpigenesis, GeneticFluorescent Antibody TechniqueGlucuronidaseHeparanaseHistone DemethylasesHistonesHumansMethylationMiceMice, Inbred C57BLReal-Time Polymerase Chain ReactionChromatinGlucuronidaseHeparanaseHistone DemethylasesHistonesRNA, Small Interfering

Identifiers

PMID22771948
PMCPMC3616083
OpenAlexW2011705594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.